Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel, Ther Drug Monit, vol.17, pp.642-54, 1995. ,
Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients, Clin Pharmacokinet, vol.45, pp.905-927, 2006. ,
A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits, Nephrol Dial Transplant, vol.25, pp.3096-106, 2010. ,
Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation, vol.9, issue.5, pp.304-315, 2003. ,
DOI : 10.1016/S1083-8791(03)00076-4
Current Practice of Therapeutic Drug Monitoring, pp.103-123 ,
DOI : 10.1016/B978-0-12-385467-4.00005-1
Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5, Drug Metabolism and Disposition, vol.35, issue.3, pp.350-355, 2007. ,
DOI : 10.1124/dmd.106.012161
NONMEM User's Guide -Part V: Introductory Guide, 1994. ,
Application of a gamma model of absorption to oral cyclosporin, Clin Pharmacokinet, vol.40, pp.375-82, 2001. ,
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil, Clin Pharmacokinet, vol.44, pp.837-884, 2005. ,
Performance of an Iterative Two-Stage Bayesian Technique for Population Pharmacokinetic Analysis of Rich Data Sets, Pharmaceutical Research, vol.22, issue.12, pp.2748-59, 2006. ,
DOI : 10.1007/s11095-006-9116-0
Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model, Drug Metabolism Reviews, vol.82, issue.1-2, pp.265-92, 1984. ,
DOI : 10.1007/BF01061210
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R, Therapeutic Drug Monitoring, vol.34, issue.4, pp.467-76, 2002. ,
DOI : 10.1097/FTD.0b013e31825c4ba6
Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method, Pharmaceutical Research, vol.26, issue.12, pp.2187-97, 2007. ,
DOI : 10.1007/s11095-007-9361-x
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2662, 2002. ,
DOI : 10.1002/sim.1041
Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data, Journal of Pharmacokinetics and Biopharmaceutics, vol.8, issue.5 ,
DOI : 10.1007/BF01061030
Evaluation of the Mycophenolic Acid Exposure Estimation Methods Used in the APOMYGERE, FDCC, and Opticept Trials, Transplantation, vol.90, issue.1, pp.44-51, 2010. ,
DOI : 10.1097/TP.0b013e3181e06584
Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients, European Journal of Drug Metabolism and Pharmacokinetics, vol.26, issue.6 ,
DOI : 10.1007/s13318-012-0087-8
Population pharmacokinetic study of Cyclosporine in the hematopoietic stem cell transplant recipients, Int. Journal of Clinical Pharmacology and Therapeutics, vol.51, issue.07, pp.568-75, 2013. ,
DOI : 10.5414/CP201815